Criteria of unresectability and the decision-making process
- PMID: 18773070
- PMCID: PMC2504391
- DOI: 10.1080/13651820801993540
Criteria of unresectability and the decision-making process
Abstract
Determination of the exact criteria for resectability in patients with cholangiocarcinoma and how they are most efficiently evaluated has many limitations. Among many factors taken into account in this decision-making process are: the condition of the patient, the biology of the disease, and the technical expertise of the surgeon and hospital. An attempt is made here to organize recommendations for the work-up of patients and the main criteria for resectability as best possible, keeping in mind that there will always be some limited room for exceptions, especially if the biology is favorable. Work-up and determination of resectability for patients with distal cholangiocarcinoma are more straightforward than at the other two sites of the disease (perihilar and peripheral). In general, these follow the same principles as those for other periampullary carcinomas (pancreas, ampullary, and duodenal). The work-up and determination of resectability for patients with peripheral cholangiocarcinoma can be relatively straightforward if the lesion is away from the hilus of the liver and does not involve a significant proportion of parenchyma, but can be problematic if it is more central or very large. Patients with perihilar cholangiocarcinomas are perhaps the most challenging, as factors such as patient condition, biology of the disease, local involvement of the major vessels and bile ducts at the hilum, and the future liver remnant all have a bearing in the decision-making process.
Keywords: Cholangiocarcinoma; resectability; staging.
Figures
Similar articles
-
MDCT assessment of resectability in hilar cholangiocarcinoma.Abdom Radiol (NY). 2017 Mar;42(3):851-860. doi: 10.1007/s00261-016-0943-0. Abdom Radiol (NY). 2017. PMID: 27770159
-
High-resolution computed tomography accurately predicts resectability in hilar cholangiocarcinoma.Am J Surg. 2007 Jun;193(6):702-6. doi: 10.1016/j.amjsurg.2006.10.024. Am J Surg. 2007. PMID: 17512280
-
Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria.Radiology. 2006 Apr;239(1):113-21. doi: 10.1148/radiol.2383050419. Epub 2006 Feb 7. Radiology. 2006. PMID: 16467211
-
Resection of Perihilar Cholangiocarcinoma.Surg Clin North Am. 2016 Apr;96(2):247-67. doi: 10.1016/j.suc.2015.12.008. Surg Clin North Am. 2016. PMID: 27017863 Review.
-
Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system.Ann Surg. 1998 Sep;228(3):385-94. doi: 10.1097/00000658-199809000-00011. Ann Surg. 1998. PMID: 9742921 Free PMC article. Review.
Cited by
-
Biliary tract cancers: moving from the present standards of care towards the use of immune checkpoint inhibitors.Am J Transl Res. 2021 Aug 15;13(8):8598-8610. eCollection 2021. Am J Transl Res. 2021. PMID: 34539982 Free PMC article. Review.
-
A tailored approach in lymph node-positive perihilar cholangiocarcinoma.Langenbecks Arch Surg. 2021 Aug;406(5):1499-1509. doi: 10.1007/s00423-021-02154-4. Epub 2021 Jun 1. Langenbecks Arch Surg. 2021. PMID: 34075473 Free PMC article.
-
Advanced biliary tract cancer: clinical outcomes with ABC-02 regimen and analysis of prognostic factors in a tertiary care center in the United States.J Gastrointest Oncol. 2016 Dec;7(6):996-1003. doi: 10.21037/jgo.2016.09.10. J Gastrointest Oncol. 2016. PMID: 28078124 Free PMC article.
-
Resectable Cholangiocarcinoma: Reviewing the Role of Adjuvant Strategies.Clin Med Insights Oncol. 2016 May 12;10:43-8. doi: 10.4137/CMO.S32821. eCollection 2016. Clin Med Insights Oncol. 2016. PMID: 27199577 Free PMC article. Review.
-
Multi-Disciplinary Care of Hilar Cholangiocarcinoma: Review of Guidelines and Recent Advancements.Cancers (Basel). 2023 Dec 20;16(1):30. doi: 10.3390/cancers16010030. Cancers (Basel). 2023. PMID: 38201457 Free PMC article. Review.
References
-
- Otto G, Romaneehsen B, Hoppe-Lotichius M, Bittinger F. Hilar cholangiocarcinoma: resectability and radicality after routine diagnostic imaging. J Hepatobil Pancreat Surg. 2004;11:310–18. - PubMed
-
- Goere D, Wagholikar GD, Pessaux P, Carrère N, Sibert A, Vilgrain S, et al. Utility of staging laparoscopy in subsets of biliary cancers. Surg Endosc. 2006;20:721–5. - PubMed
-
- Nimura Y, Kamiya J, Kondo S, Nagino M, Uesaka K, Oda K, et al. Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience. J Hepatobil Pancreat Surg. 2000;7:155–62. - PubMed
LinkOut - more resources
Full Text Sources